APA (7th ed.) Citation

RB, C., CSR, N., AJF, C., OST, G., RBB, P., SC, N., & CFS, M. (2025). Response Prediction to Neoadjuvant Chemoradiotherapy in Rectal Cancer Based on Systemic Inflammatory Markers (NLR, PLR, and LMR). Journal of gastrointestinal cancer, 56(1), 134. https://doi.org/10.1007/s12029-025-01255-3

Chicago Style (17th ed.) Citation

RB, Coser, Nahas CSR, Cassenote AJF, Ghani OST, Pinheiro RBB, Nahas SC, and Marques CFS. "Response Prediction to Neoadjuvant Chemoradiotherapy in Rectal Cancer Based on Systemic Inflammatory Markers (NLR, PLR, and LMR)." Journal of Gastrointestinal Cancer 56, no. 1 (2025): 134. https://doi.org/10.1007/s12029-025-01255-3.

MLA (9th ed.) Citation

RB, Coser, et al. "Response Prediction to Neoadjuvant Chemoradiotherapy in Rectal Cancer Based on Systemic Inflammatory Markers (NLR, PLR, and LMR)." Journal of Gastrointestinal Cancer, vol. 56, no. 1, 2025, p. 134, https://doi.org/10.1007/s12029-025-01255-3.